ClearPoint Neuro (CLPT) Return on Capital Employed Growth (3y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROCE Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -1,962.00 |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 214.00 |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 31.00 |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 355.00 |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | -846.00 |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 1,318.00 |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -247.00 |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 362.00 |
| 10 | ClearPoint Neuro | 375.84 Mn | 340.24 Mn | 7.76 Mn | 808.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 808.00 |
| Dec 31, 2025 | -261.00 |
| Sep 30, 2025 | -1,253.00 |
| Jun 30, 2025 | -2,938.00 |
| Mar 31, 2025 | -5,287.00 |
| Dec 31, 2024 | -4,583.00 |
| Sep 30, 2024 | -3,075.00 |
| Jun 30, 2024 | -3,768.00 |
| Mar 31, 2024 | -4,875.00 |
| Dec 31, 2023 | -3,499.00 |
| Sep 30, 2023 | -2,662.00 |
| Jun 30, 2023 | -2,366.00 |
| Mar 31, 2023 | -461.00 |
| Dec 31, 2022 | 1,928.00 |
| Sep 30, 2022 | 1,595.00 |
| Jun 30, 2022 | 3,329.00 |
| Mar 31, 2022 | 6,245.00 |
| Dec 31, 2021 | 6,057.00 |
| Sep 30, 2021 | 5,600.00 |
| Jun 30, 2021 | 10,016.00 |
| Mar 31, 2021 | 8,063.00 |
| Sep 30, 2019 | 12,992.00 |
| Jun 30, 2019 | 16,888.00 |
| Mar 31, 2019 | 7,357.00 |
| Sep 30, 2018 | -157,887.00 |
| Jun 30, 2018 | -635,294.00 |
| Mar 31, 2018 | 6,699.00 |
| Sep 30, 2016 | -2,648.00 |
| Jun 30, 2016 | -15,754.00 |
| Mar 31, 2016 | -4,819.00 |
| Sep 30, 2015 | 139,885.00 |
| Jun 30, 2015 | 613,446.00 |
| Mar 31, 2015 | -24,977.00 |